Showing 1 - 20 results of 3,943 for search '(( free ((a decrease) OR (small decrease)) ) OR ( a ((larger decrease) OR (marked decrease)) ))', query time: 0.54s Refine Results
  1. 1

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

    Published 2024
    “…Serum samples after bevacizumab treatment with an additional 2, 20, or 200 μg/mL of bevacizumab were compared to control samples without bevacizumab, indicating that free VEGF-A121 remained even at high doses of bevacizumab addition. …”
  8. 8
  9. 9

    Biases in larger populations. by Sander W. Keemink (21253563)

    Published 2025
    “…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Experimental assessment of the effects of substrate choice on the duration of chemical signals in fecal scent-marks of free-ranging Iberian wolves by Elisa Espartosa (16991340)

    Published 2025
    “…Substrate temperature only influenced the persistence of some chemical compounds, though lower temperatures may slightly prolong scent mark duration. These results suggest that, when wolves select a substrate to deposit the feces, enhancing visual cues (for example, different conspicuity of the feces in different substrates) may play a more important role in fecal marking than trying to increase the persistence of the olfactory signal. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20